AMGN vs GILD — stock comparison
Amgen Inc. (AMGN) vs Gilead Sciences, Inc. (GILD): price, valuation, margins, growth and Traddx's fundamentals grade, side by side. Free, live data.
On Traddx's fundamentals score, AMGN grades higher (A 81 vs D 33). Not investment advice.
1-year price performance — higher line = stronger return
■ AMGN +40.1%■ GILD +29.5%Past year, both rebased to 100
| AMGN | GILD | |
|---|---|---|
| Traddx grade | A (81) | D (33) |
| Price | $400.90 | $143.53 |
| Today | -0.52% | -0.76% |
| P/E | 24.60 | — |
| Net margin | 23.60% | -11.70% |
| Revenue (TTM) | $37,408.00M | $29,614.00M |
| Debt / equity | — | — |
| 52-week high | $447.03 | $157.29 |
| 52-week low | $288.00 | $112.82 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.